Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-04

Clinical Trial Update: AT1R Blockade and Periodic Breathing During Sleep in Hypoxia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated AT1R blockade effects on periodic breathing during sleep under hypoxic conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AT1R blocker

Snippet

Sponsor: University of British Columbia | Conditions: Sleep Disordered Breathing, Hypoxia | Phase 4 | Status: COMPLETED